poloxamer - CISMeF

Preferred Label : poloxamer;

MeSH definition : A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO(C2H4O)a(-C3H6O)b(C2H4O)aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. (Martindale The Extra Pharmacopoeia, 31st ed);

MeSH Hyperonym : poloxamers;

MeSH hyponym : poloxamer 2930; pluronic F-108; poloxamer 188; poloxamer 338; poloxamer 213; pluronic L-81; pluronic L-101; pluronic L-121; pluronic F68; poloxalkol; pluronics; poloxamer 407; pluronic F-127; Pluronic F 108; Pluronic F108; Pluronic F 127; Pluronic F127; Pluronic F-68; Pluronic F 68; Pluronic L 101; Pluronic L101; Pluronic L 121; Pluronic L121; Pluronic L 81; Pluronic L81; 188s, Poloxamer; Poloxamer 188s; 338s, Poloxamer; Poloxamer 338s; 407s, Poloxamer; Poloxamer 407s; F68s, Pluronic; Pluronic F68s; Pluronic; Poloxalkols; 213s, Poloxamer; Poloxamer 213s; 2930s, Poloxamer; Poloxamer 2930s;

MeSH CAS label : alpha-Hydro-omega-hydroxypoly(oxyethylene)a-poly(oxopropylene)b-poly(oxyethylene)a block copolymer;

Registry Number MeSH : 106392-12-5;

Wikipedia link : https://en.wikipedia.org/wiki/Poloxamers;

Is substance : O;

Details

Origin ID

D020442;

UMLS CUI

C0600615;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
CISMeF manual mappings
- poloxamer [Substance BNPC]
Currated CISMeF NLP mapping
- Poloxamer [ICD-11 Extension code]
Pharmacological action(s)
- excipients [MeSH Descriptor]
- surface-active agents [MeSH Descriptor]
Record concept(s)
- pluronic F-108 [MeSH concept]
- pluronic F-127 [MeSH concept]
- pluronic F68 [MeSH concept]
- pluronic L-101 [MeSH concept]
- pluronic L-121 [MeSH concept]
- pluronic L-81 [MeSH concept]
- pluronics [MeSH concept]
- poloxalkol [MeSH concept]
- poloxamer [MeSH concept]
- poloxamer 188 [MeSH concept]
- poloxamer 213 [MeSH concept]
- poloxamer 2930 [MeSH concept]
- poloxamer 338 [MeSH concept]
- poloxamer 407 [MeSH concept]
- poloxamers [MeSH concept]
Related MeSH Supplementary Concept(s)
- F-127 compound [MeSH Supplementary Concept]
- LeGoo [MeSH Supplementary Concept]
- NB-402 nanoemulsion [MeSH Supplementary Concept]
- P-123 compound [MeSH Supplementary Concept]
- SIC-8000 [MeSH Supplementary Concept]
- SP 1049C [MeSH Supplementary Concept]
- SP1017 [MeSH Supplementary Concept]
- Ultramulsion [MeSH Supplementary Concept]
- lumagel [MeSH Supplementary Concept]
- orthoblast II [MeSH Supplementary Concept]
- ostene [MeSH Supplementary Concept]
- pluronic L61 [MeSH Supplementary Concept]
- pluronic L64 [MeSH Supplementary Concept]
- pluronic P105 [MeSH Supplementary Concept]
- poloxamer-iodone [MeSH Supplementary Concept]
- poly(epsilon-caprolactone)-b-poloxamer-b-poly(epsilon-caprolactone) [MeSH Supplementary Concept]
- polyrotaxane [MeSH Supplementary Concept]
- pre-seed [MeSH Supplementary Concept]
- pseudopolyrotaxane [MeSH Supplementary Concept]
Semantic type(s)
- Biomedical or Dental Material [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Poloxamer [ICD-11 Extension code]
- Poloxamer [NCIt concept]
- poloxamer [Substance BNPC]
Validated automatic mappings to BTNT
- Poloxamer 188 (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients